Results 81 to 90 of about 168,097 (250)

Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction [PDF]

open access: yes, 2017
Background Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterized by impaired exercise capacity due to shortness of breath and/or fatigue.
Abbate, Antonio   +7 more
core   +2 more sources

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction [PDF]

open access: bronze, 2021
Burkert Pieske   +99 more
openalex   +1 more source

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Sparce data suggest higher mortality in heart failure (HF) with left ventricular ejection fraction (EF) >65% to 70%. We characterized EF distribution, characteristics, and outcomes in patients with HF and EF ≥50%.
Laura Landucci   +6 more
doaj   +1 more source

Treatment of heart failure with preserved ejection fraction

open access: yesMonaldi Archives for Chest Disease, 2018
Heart failure, in its diverse forms based on the value of the ejection fraction, is associated to high mortality and the frequent need for hospitalization, with a consequent heavy burden on healthcare resources.
Alfredo Monteverde   +4 more
doaj   +1 more source

Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials [PDF]

open access: gold, 2023
Karl‐Patrik Kresoja   +8 more
openalex   +1 more source

Particularities of rhythm and conduction disorders in heart failure patients with preserved ejection fraction admitted to a rehabilitation hospital [PDF]

open access: yesBalneo and PRM Research Journal
(1) Background: The mortality and prognosis of patients with heart failure with preserved ejection fraction have shown minimal improvement over the past 20 years, possibly since this condition is often accompanied by various other cardiovascular risk ...
Marius-Dragoș Mihăilă, Dana Pop
doaj   +1 more source

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial

open access: yesESC Heart Failure, 2022
Aims In the heart failure (HF) with preserved ejection fraction (HFpEF) PARAGON‐HF trial, sacubitril/valsartan vs. valsartan improved mortality/morbidity in patients with left ventricular ejection fraction (LVEF) below median (57%).
Lars H. Lund   +9 more
doaj   +1 more source

Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis [PDF]

open access: gold, 2022
Yujiao Shi   +7 more
openalex   +1 more source

A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction

open access: yesCirculation, 2018
Background: Diagnosis of heart failure with preserved ejection fraction (HFpEF) is challenging in euvolemic patients with dyspnea, and no evidence-based criteria are available.
Y. Reddy   +4 more
semanticscholar   +1 more source

Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure [PDF]

open access: yes, 2017
[Abstract] Epicardial adipose tissue has been proposed to participate in the pathogenesis of heart failure. The aim of our study was to assess the expression of thermogenic genes (Uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor ...
Carrasco-Chinchilla, Fernando   +11 more
core   +5 more sources

Home - About - Disclaimer - Privacy